Impact of beta-blockers on prostate cancer mortality: a meta-analysis of 16,825 patients

References

• SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
   PubMed Web of Science ®Google Scholar
• HanSZhangSChenWAnalysis of the status and trends of prostate cancer incidence in ChinaChin Clin Oncol201304330334 Chinese
   Google Scholar
• HanSZhangSChenWAnalysis of the status and trends of prostate cancer mortality in ChinaChin J Urol20123311836839 Chinese
   Google Scholar
• HeidenreichABastianPJBellmuntJEAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013Eur Urol201465112413724207135
   PubMed Web of Science ®Google Scholar
• ColeSWSoodAKMolecular pathways: beta-adrenergic signaling in cancerClin Cancer Res20121851201120622186256
   PubMed Web of Science ®Google Scholar
• SloanEKPricemanSJCoxBFThe sympathetic nervous system induces a metastatic switch in primary breast cancerCancer Res201070187042705220823155
   PubMed Web of Science ®Google Scholar
• CampbellJPKarolakMRMaYStimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in micePLoS Biol2012107e100136322815651
   PubMed Web of Science ®Google Scholar
• ThakerPHHanLYKamatAAChronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinomaNat Med200612893994416862152
   PubMed Web of Science ®Google Scholar
• PalmDLangKNiggemannBThe norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockersInt J Cancer2006118112744274916381019
   PubMed Web of Science ®Google Scholar
• PasquierEStreetJPouchyCbeta-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastomaBr J Cancer2013108122485249423695022
   PubMed Web of Science ®Google Scholar
• WolterJKWolterNEBlanchAAnti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastomaOncotarget20145116117224389287
   PubMedGoogle Scholar
• PasquierECiccoliniJCarreMPropranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatmentOncotarget201121079780922006582
   PubMed Web of Science ®Google Scholar
• BotteriEMunzoneERotmenszNTherapeutic effect of beta-blockers in triple-negative breast cancer postmenopausal womenBreast Cancer Res Treat2013140356757523912960
   PubMed Web of Science ®Google Scholar
• De GiorgiVGandiniSGrazziniMBenemeiSMarchionniNGeppettiPEffect of beta-blockers and other antihypertensive drugs on the risk of melanoma recurrence and deathMayo Clin Proc201388111196120324182700
   PubMed Web of Science ®Google Scholar
• WangHMLiaoZXKomakiRImproved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapyAnn Oncol20132451312131923300016
   PubMed Web of Science ®Google Scholar
• JansenLHoffmeisterMArndtVChang-ClaudeJBrennerHStage-specific associations between beta blocker use and prognosis after colorectal cancerCancer201412081178118624415516
   PubMed Web of Science ®Google Scholar
• ShahSMCareyIMOwenCGHarrisTDewildeSCookDGDoes beta-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort studyBr J Clin Pharmacol201172115716121453301
   PubMed Web of Science ®Google Scholar
• GrytliHHFagerlandMWFossaSDTaskenKAHaheimLLUse of beta-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapyProstate201373325026022821802
   PubMed Web of Science ®Google Scholar
• CardwellCRColemanHGMurrayLJO’SullivanJMPoweDGBeta-blocker usage and prostate cancer survival: A nested case-control study in the UK Clinical Practice Research Datalink cohortCancer Epidemiol201438327928524786858
   PubMed Web of Science ®Google Scholar
• GrytliHHFagerlandMWFossaSDTaskenKAAssociation between use of beta-blockers and prostate cancer-specific survival: a cohort study of 3,561 prostate cancer patients with high-risk or metastatic diseaseEur Urol201465363564123351721
   PubMed Web of Science ®Google Scholar
• StroupDFBerlinJAMortonSCMeta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) groupJAMA2000283152008201210789670
   PubMed Web of Science ®Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
   PubMedGoogle Scholar
• HigginsJPThompsonSGQuantifying heterogeneity in a meta-analysisStat Med200221111539155812111919
   PubMed Web of Science ®Google Scholar
• AssayagJPollakMNAzoulayLPost-diagnostic use of beta-blockers and the risk of death in patients with prostate cancerEur J Cancer201450162838284525204805
   PubMed Web of Science ®Google Scholar
• LutgendorfSKColeSCostanzoEStress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell linesClin Cancer Res20039124514452114555525
   PubMed Web of Science ®Google Scholar
• BenishMBartalIGoldfarbYPerioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasisAnn Surg Oncol20081572042205218398660
   PubMed Web of Science ®Google Scholar
• Kim-FuchsCLeCPPimentelMAChronic stress accelerates pancreatic cancer growth and invasion: A critical role for beta-adrenergic signaling in the pancreatic microenvironmentBrain Behav Immun201440404724650449
   PubMed Web of Science ®Google Scholar
• HassanSKarpovaYBaizDBehavioral stress accelerates prostate cancer development in miceJ Clin Invest2013123287488623348742
   PubMed Web of Science ®Google Scholar
• PerronLBairatiIHarelFMeyerFAntihypertensive drug use and the risk of prostate cancer (Canada)Cancer Causes Control200415653554115280632
   PubMed Web of Science ®Google Scholar
• KemppainenKJTammelaTLAuvinenAMurtolaTJThe association between antihypertensive drug use and incidence of prostate cancer in Finland: a population-based case-control studyCancer Causes Control201122101445145221769492
   PubMed Web of Science ®Google Scholar
• MitaACFiglinRMitaMMCabazitaxel: more than a new taxane for metastatic castrate-resistant prostate cancerClin Cancer Res201218246574657923091116
   PubMed Web of Science ®Google Scholar
• SchutzFABuzaidACSartorOTaxanes in the management of metastatic castration-resistant prostate cancer: efficacy and management of toxicityCrit Rev Oncol Hematol201491324825624613528
   PubMed Web of Science ®Google Scholar